Sign in
Active, not recruitingNo phase

Radiomics Features Predicting Outcomes of PAD

Key facts

Who runs it
Zhijun Bao
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
200 people, planned
Started
1 Apr 2026
Expected to end
31 Dec 2026
Type of study
Observational
Treatments tested
  • Non interventional study
Record updated
22 May 2026

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • aged between 18 and 100 years
  • meeting the diagnostic criteria for peripheral artery disease (PAD)
  • successfully undergoing interventional surgery
  • successfully completing preoperative lower limb CTA or MRA examination with good image quality, suitable for radiomics analysis

Who cannot take part

  • Heart failure (NYHA class III/IV)
  • right-to-left shunt heart disease
  • severe aortic and mitral valve insufficiency
  • acute coronary syndrome, or malignant arrhythmia
  • severe pulmonary hypertension (pulmonary artery pressure >90mmHg)
  • any allergic constitution
  • moderate to severe renal insufficiency (creatinine clearance rate <60ml/min)
  • pregnancy and childbirth period
  • life expectancy <12 months
  • poor image quality, unable to analyze
  • incomplete medical history data

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

There is a high risk of restenosis and vascular occlusion after interventional treatment for peripheral arterial disease (PAD), and some severe patients inevitably end up with amputation. Perivascular adipose tissue (PVAT) has been recognized not only as an inert tissue providing mechanical support, but also as a highly active endocrine and paracrine organ, which could provide a new imaging perspective into the pathophysiological mechanism of lower limb atherosclerosis microenvironment. The aim of this study is to identify novel and reliable non-invasive imaging biomarkers by exploring the potential association between lower limb PVAT imaging omics features and clinical outcomes (including death, major amputation, target vessel revascularization, etc.) in patients with PAD after interventional treatment. The study aims to offer clinicians with more accurate personalized risk stratification tools before surgery, thereby optimizing clinical decision-making and helping to achieve precision medicine for PAD.

The group in the trial

  • patients of peripheral artery disease

    patients of peripheral artery disease after intervention

    Treatment: Non interventional study

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Radiomics Features for Predicting Clinical Outcomes in Peripheral Artery Disease
Record updated
22 May 2026